Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 19, 2002

View Archived Issues

Maxim reports advances in its proapoptotic drug discovery program

Replikins: new targets for the detection and treatment of cancer

Potential antianginal efficacy of the selective, orally active Na+/H+ exchange inhibitor SMP-300

Hollis-Eden collaborating on development of Aeson's lead compound

3-DP licenses GSK TPO mimetic

Natural antibacterial compound acts by inhibiting protein translocation

Microbial metabolite pipalamycin induces apoptosis in cancer cells

RWJ-54428 active against a wide spectrum of resistant Gram-positive cocci

MDA-7 expression lost with progression of melanoma; data support use of INGN-241 in melanoma

Cidecin safe and effective in complicated urinary tract infections

Four compounds targeted for clinical development at ExonHit

Orphan drug status granted for SS1-PE38 in mesothelioma and ovarian cancer

Surfaxin granted orphan drug status in ALI/ARDS

Interneuron highlights recent accomplishments, announces name change

Active Biotech presents annual account for 2001

Aciphex indications expanded

KW-6002 completes phase IIa trials in Parkinson's disease

Yamanouchi gains access to TransGenic knockout mice gene function information

Insmed and Oxagen collaborate on genetic study of PCOS

Takeda takes control of joint venture with Gruenenthal

Compounds with affinity for 5-HT1A receptors described in patent by Knoll

Abbott claims phenylsulfanyl derivatives for inflammation, etc.

Selective inhibitors of COX-2 synthesized at Merck Frosst

Taisho identifies compounds with use in psychiatric and neurological disorders

Pyrrole derivatives with HIV reverse transcriptase-inhibitory activity described in patent

Sugen prepares inhibitors of protein kinases with potential in cancer, etc.

ABI-007 status in breast cancer updated

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...